| 영문 | milk | 한글 | 젖, 우유 |
|---|---|---|---|
| 설명 | 1. 미숙 포유동물의 자연식품이 되는 젓샘의 액체분비물. 아미의 젖샘에서 생성-분비되는 액체. 갓 태어난 새끼를 양육하기 위해 어미가 생산하는 완벽한 자연영양식품으로, 출산 후 처음으로 나오는 젖을 초유라고 하며, 백혈구나 지방립을 품고 있어서 황색을 띠지만 며칠 지나면 흰 빛깔의 젖으로 변한다. 약 87%의 수분 외에 젖당-지방-단백질-비타민-무기질을 함유하지만, 철-구리-비타민 C, D의 함유량은 낮아 주의할 필요가 있다. |
||
| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
|---|---|
| FSP | familial spastic paraplegia; fibrin split products; fibrinogen split products; fine suspended partic... |
| CMA | Canadian Medical Association; Certified Medical Assistant; chronic metabolic acidosis; cow's milk al... |
| CCS | Canadian Cardiovascular Society; casualty clearing station; cell cycle specific; cholecystosonograph... |
| CTC | chlortetracycline; Clinical Trial Certificate; computed tomographic colography; computer-aided tomog... |
| CTC | Cultured T cells |
|---|---|
| CEA | Cultured epidermal autograft |
| CEA | Cultured epithelial autograft |
| CMC | Cultured mast cells |
| CSS | Cultured skin substitutes |
| cells, cultured | Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. (12 Dec 1998) |
|---|---|
| cultured | <cell culture> The process of incubating viruses or bacteria from tissue or other body fluids, for the purpose of identification. (27 Sep 1997) |
| tumour cells, cultured | Cells grown in vitro from neoplastic tissue for use in studying the proliferative and metabolic capacities of tumour cells, in predicting clinical responses to chemotherapy, in screening new antitumour agents, and in basic biological research. They include carcinoma cell lines. (12 Dec 1998) |
| biological products | Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms. (12 Dec 1998) |
| blood products | Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered. (14 Nov 1997) |
| gene products, env | Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesised as protein precursors (polyproteins) and later cleaved into the final products by a viral protease. (12 Dec 1998) |
| gene products, gag | Proteins coded by the retroviral gag gene. The products are usually synthesised as protein precursors or polyproteins, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. Gag is short for group-specific antigen. (12 Dec 1998) |
| gene products, nef | Products of the HIV nef gene (formerly 3'-orf gene). The products trans-suppress viral replication and function as negative regulators of transcription. Nef stands for negative factor. (12 Dec 1998) |
| gene products, pol | Retroviral proteins coded by the pol gene. Often synthesised as a gag-pol fusion protein (fusion proteins, gag-pol) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Pol is short for polymerase, the enzyme class of reverse transcriptase. (12 Dec 1998) |
| gene products, rev | Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. Rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (car) in env, also known as the rev-responsive element (rre), is responsive to the rev gene product. Rev is short for regulator of virion. (12 Dec 1998) |
| gene products, rex | Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HTLV-I and HTLV-II. The rex (regulator x; x is undefined) products act by binding to elements in the ltr. (12 Dec 1998) |
| gene products, tat | Trans-acting transcription factors. Nuclear proteins whose expression is required for HIV viral replication. The tat protein stimulates HIV-ltr-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. (12 Dec 1998) |
| gene products, tax | Transcriptional trans-acting proteins of the promoter elements found in the long-terminal repeats (ltr) of HTLV-I and HTLV-II. The tax (trans-activator x; x is undefined) proteins act by binding to enhancer elements in the ltr. (12 Dec 1998) |
| gene products, vif | A 23 kD regulatory protein important for virion infectivity in HIV. The protein is found in the cytoplasm of HIV-infected cells and is not absolutely required for virion formation. (12 Dec 1998) |
| gene products, vpr | Trans-acting proteins which accelerate virus replication in HIV. The vpr proteins act in trans to increase the levels of HIV specified proteins. Vpr is short for viral protein r, where r is undefined. (12 Dec 1998) |
Synonyms : Fermented Milk Products, Milk Products, Cultured, Cultured Milk Product, Fermented Milk Product, Milk Product, Cultured, Milk Product, Fermented, Milk Products, Fermented, Product, Cultured Milk, Product, Fermented Milk, Products, Cultured Milk
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|